Lectin-Dependent Enhancement of Ebola Virus Infection via Soluble and Transmembrane C-type Lectin Receptors

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Brudner, Matthew ^a   Karpel, Marshall ^a   Lear, Calli ^b   Chen, Li ^a   Yantosca, L Michael ^a   Scully, Corinne ^b   Sarraju, Ashish ^a   Sokolovska, Anna ^a   Zariffard, M Reza ^c   Eisen, Damon P ^d   Mungall, Bruce A ^e   Kotton, Darrell N ^f   Omari, Amel ^f   Huang, I Chueh ^g,j   Farzan, Michael ^g,h,k   Takahashi, Kazue ^a,h   Stuart, Lynda ^a,h   Stahl, Gregory L ^g,h   Ezekowitz, Alan B ^a   Spear, Gregory T ^c   Olinger, Gene G ^b   Schmidt, Emmett V ^a,h   Michelow, Ian C ^a,h,i   more..

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d ROYAL MELBOURNE HOSPITAL   (Australia)

^e CSIRO   (Australia)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ BROWN UNIVERSITY   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k University of California Riverside ^*  (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q BINDING PROTEIN; COMPLEMENT COMPONENT C4; DECTIN 2; GLYCAN; GLYCOPROTEIN; LECTIN RECEPTOR; MANNOSE BINDING LECTIN; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ADULT; ARTICLE; COMPLEMENT COMPONENT C4 GENE; CONTROLLED STUDY; EBOLA HEMORRHAGIC FEVER; EBOLA VIRUS; FEMALE; HAPLOTYPE; HENDRA VIRUS INFECTION; HUMAN; HUMAN CELL; HYPOCOMPLEMENTEMIA; INNATE IMMUNITY; MALE; NIPAH VIRUS INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PINOCYTOSIS; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN FUNCTION; PSEUDOTYPING; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS; WEST NILE FLAVIVIRUS;

ANIMALS; CERCOPITHECUS AETHIOPS; COMPLEMENT SYSTEM PROTEINS; EBOLAVIRUS; FILOVIRIDAE INFECTIONS; HEK293 CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; MANNOSE-BINDING LECTIN; MEMBRANE GLYCOPROTEINS; PINOCYTOSIS; RECEPTORS, MITOGEN; VERO CELLS; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION;

EBOLA VIRUS; MARBURGVIRUS; WEST NILE VIRUS;

EID: 84875658921     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060838     Document Type: Article

References (102)

1. Rouse BT, Sehrawat S, (2010) Immunity and immunopathology to viruses: what decides the outcome? Nat Rev Immunol 10: 514-526.
2. Bowie AG, Unterholzner L, (2008) Viral evasion and subversion of pattern-recognition receptor signalling. Nat Rev Immunol 8: 911-922.
3. Ip WK, Takahashi K, Moore KJ, Stuart LM, Ezekowitz RA, (2008) Mannose-binding lectin enhances Toll-like receptors 2 and 6 signaling from the phagosome. J Exp Med 205: 169-181.
4. Ip WK, Takahashi K, Ezekowitz RA, Stuart LM, (2009) Mannose-binding lectin and innate immunity. Immunol Rev 230: 9-21.
5. Takahashi K, Ip WE, Michelow IC, Ezekowitz RA, (2006) The mannose-binding lectin: a prototypic pattern recognition molecule. Curr Opin Immunol 18: 16-23.
6. Michelow IC, Dong M, Mungall BA, Yantosca LM, Lear C, et al. (2010) A novel L-ficolin/mannose-binding lectin chimeric molecule with enhanced activity against Ebola virus. J Biol Chem 285: 24729-24739.
7. Thiel S, (2007) Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectin, ficolins and associated proteins. Mol Immunol 44: 3875-3888.
8. Madsen HO, Satz ML, Hogh B, Svejgaard A, Garred P, (1998) Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. J Immunol 161: 3169-3175.
9. Casanova JL, Abel L, (2004) Human Mannose-binding Lectin in Immunity: Friend, Foe, or Both? J Exp Med 199: 1295-1299.
10. Klein NJ, (2005) Mannose-binding lectin: do we need it? Mol Immunol 42: 919-924.
11. Bernig T, Taylor JG, Foster CB, Staats B, Yeager M, et al. (2004) Sequence analysis of the mannose-binding lectin (MBL2) gene reveals a high degree of heterozygosity with evidence of selection. Genes Immun 5: 461-476.
12. Zampieri CA, Sullivan NJ, Nabel GJ, (2007) Immunopathology of highly virulent pathogens: insights from Ebola virus. Nat Immunol 8: 1159-1164.
13. Dolnik O, Kolesnikova L, Becker S, (2008) Filoviruses: Interactions with the host cell. Cell Mol Life Sci 65: 756-776.
14. Ji X, Olinger GG, Aris S, Chen Y, Gewurz H, et al. (2005) Mannose-binding lectin binds to Ebola and Marburg envelope glycoproteins, resulting in blocking of virus interaction with DC-SIGN and complement-mediated virus neutralization. J Gen Virol 86: 2535-2542.
15. Michelow IC, Lear C, Scully C, Prugar LI, Longley CB, et al. (2011) High-dose mannose-binding lectin therapy for ebola virus infection. J Infect Dis 203: 175-179.
16. Mercer J, Schelhaas M, Helenius A, (2010) Virus entry by endocytosis. Annu Rev Biochem 79: 803-833.
17. Saeed MF, Kolokoltsov AA, Albrecht T, Davey RA, (2010) Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes. PLoS Pathog 6.
18. Cote M, Misasi J, Ren T, Bruchez A, Lee K, et al. (2011) Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature 477: 344-348.
19. Kondratowicz AS, Lennemann NJ, Sinn PL, Davey RA, Hunt CL, et al. (2011) T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus. Proc Natl Acad Sci U S A.
20. Halstead SB, Mahalingam S, Marovich MA, Ubol S, Mosser DM, (2010) Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect Dis 10: 712-722.
21. Takada A, Kawaoka Y, (2003) Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications. Rev Med Virol 13: 387-398.
22. Takada A, Ebihara H, Feldmann H, Geisbert TW, Kawaoka Y, (2007) Epitopes required for antibody-dependent enhancement of Ebola virus infection. J Infect Dis 196Suppl 2: S347-356.
23. Hawkes RA, (1964) Enhancement of the Infectivity of Arboviruses by Specific Antisera Produced in Domestic Fowls. Aust J Exp Biol Med Sci 42: 465-482.
24. Oswald WB, Geisbert TW, Davis KJ, Geisbert JB, Sullivan NJ, et al. (2007) Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys. PLoS Pathog 3: e9.
25. Mehlhop E, Nelson S, Jost CA, Gorlatov S, Johnson S, et al. (2009) Complement protein C1q reduces the stoichiometric threshold for antibody-mediated neutralization of West Nile virus. Cell Host Microbe 6: 381-391.
26. Ezekowitz RA, (1991) Ante-antibody immunity. Curr Biol 1: 60-62.
27. Pagh R, Duus K, Laursen I, Hansen PR, Mangor J, et al. (2008) The chaperone and potential mannan-binding lectin (MBL) co-receptor calreticulin interacts with MBL through the binding site for MBL-associated serine proteases. FEBS J 275: 515-526.
28. McGreal E, Gasque P, (2002) Structure-function studies of the receptors for complement C1q. Biochem Soc Trans 30: 1010-1014.
29. Matei E, Zheng A, Furey W, Rose J, Aiken C, et al. (2010) Anti-HIV activity of defective cyanovirin-N mutants is restored by dimerization. J Biol Chem 285: 13057-13065.
30. Vorup-Jensen T, Sorensen ES, Jensen UB, Schwaeble W, Kawasaki T, et al. (2001) Recombinant expression of human mannan-binding lectin. Int Immunopharmacol 1: 677-687.
31. Collard CD, Vakeva A, Morrissey MA, Agah A, Rollins SA, et al. (2000) Complement activation after oxidative stress: role of the lectin complement pathway. Am J Pathol 156: 1549-1556.
32. Steffensen R, Thiel S, Varming K, Jersild C, Jensenius JC, (2000) Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J Immunol Methods 241: 33-42.
33. Medina MF, Kobinger GP, Rux J, Gasmi M, Looney DJ, et al. (2003) Lentiviral vectors pseudotyped with minimal filovirus envelopes increased gene transfer in murine lung. Mol Ther 8: 777-789.
34. Towner JS, Paragas J, Dover JE, Gupta M, Goldsmith CS, et al. (2005) Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening. Virology 332: 20-27.
35. Hyatt AD, Selleck PW, (1996) Ultrastructure of equine morbillivirus. Virus Res 43: 1-15.
36. Shiell BJ, Gardner DR, Crameri G, Eaton BT, Michalski WP, (2003) Sites of phosphorylation of P and V proteins from Hendra and Nipah viruses: newly emerged members of Paramyxoviridae. Virus Res 92: 55-65.
37. Hanna SL, Pierson TC, Sanchez MD, Ahmed AA, Murtadha MM, et al. (2005) N-linked glycosylation of west nile virus envelope proteins influences particle assembly and infectivity. J Virol 79: 13262-13274.
38. Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, et al. (2009) The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139: 1243-1254.
39. Puig-Kroger A, Serrano-Gomez D, Caparros E, Dominguez-Soto A, Relloso M, et al. (2004) Regulated expression of the pathogen receptor dendritic cell-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin in THP-1 human leukemic cells, monocytes, and macrophages. J Biol Chem 279: 25680-25688.
40. Moffat J, Grueneberg DA, Yang X, Kim SY, Kloepfer AM, et al. (2006) A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 124: 1283-1298.
41. Shimojima M, Takada A, Ebihara H, Neumann G, Fujioka K, et al. (2006) Tyro3 family-mediated cell entry of Ebola and Marburg viruses. J Virol 80: 10109-10116.
42. Alvarez CP, Lasala F, Carrillo J, Muniz O, Corbi AL, et al. (2002) C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J Virol 76: 6841-6844.
43. Takada A, Fujioka K, Tsuiji M, Morikawa A, Higashi N, et al. (2004) Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry. J Virol 78: 2943-2947.
44. Powlesland AS, Fisch T, Taylor ME, Smith DF, Tissot B, et al. (2008) A novel mechanism for LSECtin binding to Ebola virus surface glycoprotein through truncated glycans. J Biol Chem 283: 593-602.
45. Chandran K, Sullivan NJ, Felbor U, Whelan SP, Cunningham JM, (2005) Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308: 1643-1645.
46. Kaletsky RL, Simmons G, Bates P, (2007) Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity. J Virol 81: 13378-13384.
47. Hood CL, Abraham J, Boyington JC, Leung K, Kwong PD, et al. (2010) Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: implications for viral entry and immunogenicity. J Virol 84: 2972-2982.
48. Dube D, Schornberg KL, Stantchev TS, Bonaparte MI, Delos SE, et al. (2008) Cell adhesion promotes Ebola virus envelope glycoprotein-mediated binding and infection. J Virol 82: 7238-7242.
49. Barrientos LG, Lasala F, Otero JR, Sanchez A, Delgado R, (2004) In vitro evaluation of cyanovirin-N antiviral activity, by use of lentiviral vectors pseudotyped with filovirus envelope glycoproteins. J Infect Dis 189: 1440-1443.
50. Francica JR, Varela-Rohena A, Medvec A, Plesa G, Riley JL, et al. (2010) Steric shielding of surface epitopes and impaired immune recognition induced by the ebola virus glycoprotein. PLoS Pathog 6.
51. Schornberg K, Matsuyama S, Kabsch K, Delos S, Bouton A, et al. (2006) Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J Virol 80: 4174-4178.
52. Powell LD, (2001) Inhibition of N-linked glycosylation. Curr Protoc Immunol Chapter 8Unit 8 14.
53. Yonezawa A, Cavrois M, Greene WC, (2005) Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha. J Virol 79: 918-926.
54. Mercer J, Helenius A, (2008) Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science 320: 531-535.
55. Hurtado-Lorenzo A, Skinner M, El Annan J, Futai M, Sun-Wada GH, et al. (2006) V-ATPase interacts with ARNO and Arf6 in early endosomes and regulates the protein degradative pathway. Nat Cell Biol 8: 124-136.
56. Super M, Thiel S, Lu J, Levinsky RJ, Turner MW, (1989) Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet 2: 1236-1239.
57. Jack DL, Read RC, Tenner AJ, Frosch M, Turner MW, et al. (2001) Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis serogroup. B. J Infect Dis 184: 1152-1162.
58. Boldt AB, Luty A, Grobusch MP, Dietz K, Dzeing A, et al. (2006) Association of a new mannose-binding lectin variant with severe malaria in Gabonese children. Genes Immun 7: 393-400.
59. Seyfarth J, Garred P, Madsen HO, (2005) The 'involution' of mannose-binding lectin. Hum Mol Genet 14: 2859-2869.
60. Vigerust DJ, Shepherd VL, (2007) Virus glycosylation: role in virulence and immune interactions. Trends Microbiol 15: 211-218.
61. Feldmann H, Volchkov VE, Volchkova VA, Stroher U, Klenk HD, (2001) Biosynthesis and role of filoviral glycoproteins. J Gen Virol 82: 2839-2848.
62. Kuhn JH, Radoshitzky SR, Guth AC, Warfield KL, Li W, et al. (2006) Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor. J Biol Chem 281: 15951-15958.
63. Lee JE, Fusco ML, Hessell AJ, Oswald WB, Burton DR, et al. (2008) Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454: 177-182.
64. Feldmann H, Nichol ST, Klenk HD, Peters CJ, Sanchez A, (1994) Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology 199: 469-473.
65. Reynard O, Borowiak M, Volchkova VA, Delpeut S, Mateo M, et al. (2009) Ebolavirus glycoprotein GP masks both its own epitopes and the presence of cellular surface proteins. J Virol 83: 9596-9601.
66. Zhang H, Loriaux P, Eng J, Campbell D, Keller A, et al. (2006) UniPep--a database for human N-linked glycosites: a resource for biomarker discovery. Genome Biol 7: R73.
67. Nepomuceno RR, Ruiz S, Park M, Tenner AJ, (1999) C1qRP is a heavily O-glycosylated cell surface protein involved in the regulation of phagocytic activity. J Immunol 162: 3583-3589.
68. Maginnis MS, Haley SA, Gee GV, Atwood WJ, (2010) Role of N-linked glycosylation of the 5-HT2A receptor in JC virus infection. J Virol 84: 9677-9684.
69. Gardai SJ, Xiao YQ, Dickinson M, Nick JA, Voelker DR, et al. (2003) By binding SIRPalpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 115: 13-23.
70. Sanchez A, (2007) Analysis of filovirus entry into vero e6 cells, using inhibitors of endocytosis, endosomal acidification, structural integrity, and cathepsin (B and L) activity. J Infect Dis 196Suppl 2: S251-258.
71. Quinn K, Brindley MA, Weller ML, Kaludov N, Kondratowicz A, et al. (2009) Rho GTPases modulate entry of Ebola virus and vesicular stomatitis virus pseudotyped vectors. J Virol 83: 10176-10186.
72. Bhattacharyya S, Warfield KL, Ruthel G, Bavari S, Aman MJ, et al. (2010) Ebola virus uses clathrin-mediated endocytosis as an entry pathway. Virology 401: 18-28.
73. Dube D, Schornberg KL, Shoemaker CJ, Delos SE, Stantchev TS, et al. (2010) Cell adhesion-dependent membrane trafficking of a binding partner for the ebolavirus glycoprotein is a determinant of viral entry. Proc Natl Acad Sci U S A 107: 16637-16642.
74. Nanbo A, Imai M, Watanabe S, Noda T, Takahashi K, et al. (2010) Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS Pathog 6.
75. Hunt CL, Kolokoltsov AA, Davey RA, Maury W, (2010) The Tyro3 receptor kinase Axl enhances macropinocytosis of Zaire ebolavirus. J Virol 85: 334-347.
76. Bayer N, Schober D, Prchla E, Murphy RF, Blaas D, et al. (1998) Effect of bafilomycin A1 and nocodazole on endocytic transport in HeLa cells: implications for viral uncoating and infection. J Virol 72: 9645-9655.
77. Rojek JM, Sanchez AB, Nguyen NT, de la Torre JC, Kunz S, (2008) Different mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses. J Virol 82: 7677-7687.
78. Ghebrehiwet B, Lim BL, Peerschke EI, Willis AC, Reid KB, (1994) Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q. J Exp Med 179: 1809-1821.
79. Xu L, Xiao N, Liu F, Ren H, Gu J, (2009) Inhibition of RIG-I and MDA5-dependent antiviral response by gC1qR at mitochondria. Proc Natl Acad Sci U S A 106: 1530-1535.
80. Spiropoulou CF, Ranjan P, Pearce MB, Sealy TK, Albarino CG, et al. (2009) RIG-I activation inhibits ebolavirus replication. Virology 392: 11-15.
81. Dong M, Xu S, Oliveira CL, Pedersen JS, Thiel S, et al. (2007) Conformational changes in mannan-binding lectin bound to ligand surfaces. J Immunol 178: 3016-3022.
82. Kerrigan AM, Brown GD, (2011) Syk-coupled C-type lectins in immunity. Trends Immunol.
83. de Messias-Reason IJ, Boldt AB, Moraes Braga AC, Von Rosen Seeling Stahlke E, Dornelles L, et al. (2007) The association between mannan-binding lectin gene polymorphism and clinical leprosy: new insight into an old paradigm. J Infect Dis 196: 1379-1385.
84. Denholm JT, McBryde ES, Eisen DP, (2010) Mannose-binding lectin and susceptibility to tuberculosis: a meta-analysis. Clin Exp Immunol 162: 84-90.
85. Garred P, Harboe M, Oettinger T, Koch C, Svejgaard A, (1994) Dual role of mannan-binding protein in infections: another case of heterosis? Eur J Immunogenet 21: 125-131.
86. Catano G, Agan BK, Kulkarni H, Telles V, Marconi VC, et al. (2008) Independent effects of genetic variations in mannose-binding lectin influence the course of HIV disease: the advantage of heterozygosity for coding mutations. J Infect Dis 198: 72-80.
87. Tobin DM, Roca FJ, Oh SF, McFarland R, Vickery TW, et al. (2012) Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections. Cell 148: 434-446.
88. Gunn BM, Morrison TE, Whitmore AC, Blevins LK, Hueston L, et al. (2012) Mannose binding lectin is required for alphavirus-induced arthritis/myositis. PLoS Pathog 8: e1002586.
89. Ling MT, Tu W, Han Y, Mao H, Chong WP, et al. (2011) Mannose-binding lectin contributes to deleterious inflammatory response in pandemic H1N1 and avian H9N2 infection. J Infect Dis 205: 44-53.
90. Schwaeble WJ, Lynch NJ, Clark JE, Marber M, Samani NJ, et al. (2011) Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury. Proc Natl Acad Sci U S A 108: 7523-7528.
91. Wu YL, Savelli SL, Yang Y, Zhou B, Rovin BH, et al. (2007) Sensitive and specific real-time polymerase chain reaction assays to accurately determine copy number variations (CNVs) of human complement C4A, C4B, C4-long, C4-short, and RCCX modules: elucidation of C4 CNVs in 50 consanguineous subjects with defined HLA genotypes. J Immunol 179: 3012-3025.
92. Blanchong CA, Zhou B, Rupert KL, Chung EK, Jones KN, et al. (2000) Deficiencies of human complement component C4A and C4B and heterozygosity in length variants of RP-C4-CYP21-TNX (RCCX) modules in caucasians. The load of RCCX genetic diversity on major histocompatibility complex-associated disease. J Exp Med 191: 2183-2196.
93. Saxena K, Kitzmiller KJ, Wu YL, Zhou B, Esack N, et al. (2009) Great genotypic and phenotypic diversities associated with copy-number variations of complement C4 and RP-C4-CYP21-TNX (RCCX) modules: a comparison of Asian-Indian and European American populations. Mol Immunol 46: 1289-1303.
94. Kainulainen L, Peltola V, Seppanen M, Viander M, He Q, et al. C4A deficiency in children and adolescents with recurrent respiratory infections. Hum Immunol 73: 498-501.
95. Yang Y, Chung EK, Zhou B, Blanchong CA, Yu CY, et al. (2003) Diversity in intrinsic strengths of the human complement system: serum C4 protein concentrations correlate with C4 gene size and polygenic variations, hemolytic activities, and body mass index. J Immunol 171: 2734-2745.
96. Pickering MC, Botto M, Taylor PR, Lachmann PJ, Walport MJ, (2000) Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol 76: 227-324.
97. Williamson WA, Damisah M, Greenwood BM, Gilles HM, (1978) Hypocomplementaemia in children with Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 72: 676-677.
98. Phanuphak P, Hanvanich M, Sakulramrung R, Moollaor P, Sitprija V, et al. (1985) Complement changes in falciparum malaria infection. Clin Exp Immunol 59: 571-576.
99. Seyfarth J, Garred P, Madsen HO, (2006) Extra-hepatic transcription of the human mannose-binding lectin gene (mbl2) and the MBL-associated serine protease 1-3 genes. Mol Immunol 43: 962-971.
100. Li K, Sacks SH, Zhou W, (2007) The relative importance of local and systemic complement production in ischaemia, transplantation and other pathologies. Mol Immunol 44: 3866-3874.
101. Thiel S, Kolev M, Degn S, Steffensen R, Hansen AG, et al. (2009) Polymorphisms in mannan-binding lectin (MBL)-associated serine protease 2 affect stability, binding to MBL, and enzymatic activity. J Immunol 182: 2939-2947.
102. Thiel S, Steffensen R, Christensen IJ, Ip WK, Lau YL, et al. (2007) Deficiency of mannan-binding lectin associated serine protease-2 due to missense polymorphisms. Genes Immun 8: 154-163.